Developer of an optical spectroscopy-based diagnostic technology designed for early disease detection. The company's technology analyzes blood and saliva samples using optical measurement techniques, applies engineered processes to identify clinical markers and supports detection workflows for head and neck conditions, enabling oncologists and cancer centers to detect early cancer recurrence in head and neck cancer survivors, addressing the need for accurate and affordable monitoring in a market with limited options.